Articles with "pik3ca mutations" as a keyword



Photo by unstable_affliction from unsplash

Cancer-Associated PIK3CA Mutations in Overgrowth Disorders

Sign Up to like & get
recommendations!
Published in 2018 at "Trends in Molecular Medicine"

DOI: 10.1016/j.molmed.2018.08.003

Abstract: PIK3CA is one of the most commonly mutated genes in solid cancers. PIK3CA mutations are also found in benign overgrowth syndromes, collectively known as PIK3CA-related overgrowth spectrum (PROS). As in cancer, PIK3CA mutations in PROS… read more here.

Keywords: associated pik3ca; pik3ca mutations; mutations overgrowth; cancer ... See more keywords
Photo from wikipedia

Somatic PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis

Sign Up to like & get
recommendations!
Published in 2017 at "Pediatric Research"

DOI: 10.1038/pr.2017.155

Abstract: BackgroundFacial infiltrating lipomatosis (FIL) is a congenital disorder that causes overgrowth of one side of the face. The purpose of this study was to determine whether PIK3CA mutations are present in tissues outside of the… read more here.

Keywords: infiltrating lipomatosis; pik3ca mutations; tissue; mutations present ... See more keywords
Photo from wikipedia

Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors

Sign Up to like & get
recommendations!
Published in 2019 at "Science"

DOI: 10.1126/science.aaw9032

Abstract: Seeing double can be a good thing Many human breast cancers harbor activating mutations in PIK3CA, the gene coding for the catalytic subunit of phosphoinositide 3-kinase (PI3K). Clinical trials are underway to evaluate the efficacy… read more here.

Keywords: breast cancers; double pik3ca; pik3ca mutations; pi3k inhibitors ... See more keywords
Photo by nhiamoua from unsplash

Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast Carcinoma

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical Cancer Research"

DOI: 10.1158/1078-0432.ccr-22-2115

Abstract: Abstract Purpose: Alpelisib is a PI3K alpha (PI3Kα)-selective inhibitor approved for the treatment of hormone receptor–positive/HER2-negative (HR+/HER2−) PIK3CA-mutated advanced breast cancer (ABC) based on the SOLAR-1 trial, which defined 11 substitutions in exons 7, 9,… read more here.

Keywords: biology targetability; breast; alp ful; pik3ca mutations ... See more keywords
Photo from wikipedia

Abstract 1207: A systematic literature review of the prevalence of PIK3CA mutations and mutation hotspots in HR+/HER2- metastatic breast cancer

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer Research"

DOI: 10.1158/1538-7445.am2018-1207

Abstract: Introduction: Clinical research on the predictive value of PIK3CA mutations in hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2–) metastatic breast cancer (mBC) has advanced in recent years. However, knowledge of epidemiological prevalence has… read more here.

Keywords: breast; pik3ca mutations; prevalence; pik3ca ... See more keywords
Photo by nci from unsplash

Abstract 2217: Concordance of PIK3CA mutations in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer: A systematic literature review

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer Research"

DOI: 10.1158/1538-7445.am2018-2217

Abstract: Introduction: This systematic literature review sought to determine the concordance of PIK3CA mutations in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC) patients. Methods: A comprehensive search of PubMed/MEDLINE,… read more here.

Keywords: concordance; pik3ca mutations; cancer; receptor ... See more keywords
Photo from wikipedia

Abstract NG16: DoublePIK3CAmutations incisincrease oncogenicity and sensitivity to PI3Kα inhibitors

Sign Up to like & get
recommendations!
Published in 2020 at "Cancer Research"

DOI: 10.1158/1538-7445.am2020-ng16

Abstract: PIK3CA is the most frequently mutated oncogene across all human cancers, and codes for p110α, the catalytic subunit of the PI3K complex. PI3K catalyzes the phosphorylation of the lipid PIP2 to PIP3, which initiates a… read more here.

Keywords: cancer; pi3k; pik3ca mutations; breast cancer ... See more keywords
Photo from wikipedia

Abstract P3-03-01: DoublePIK3CAmutations incisdrive oncogene addiction and enhance sensitivity to PI3K alpha inhibitors in breast cancer

Sign Up to like & get
recommendations!
Published in 2020 at "Cancer Research"

DOI: 10.1158/1538-7445.sabcs19-p3-03-01

Abstract: Activating mutations in PIK3CA, the gene coding for the catalytic subunit (p110α) of phosphoinositide-3-kinase (PI3K), are the most frequent oncogenic alterations in estrogen receptor-positive (ER+) breast cancer and are also prevalent in other tumor types.… read more here.

Keywords: pik3ca mutations; breast cancer; sensitivity; double pik3ca ... See more keywords
Photo from wikipedia

Abstract A21: Compound PIK3CA mutations support a mutational dose-response model for oncogene activation and response to PI3K inhibitor targeted therapy in breast cancer

Sign Up to like & get
recommendations!
Published in 2020 at "Molecular Cancer Research"

DOI: 10.1158/1557-3125.pi3k-mtor18-a21

Abstract: PIK3CA mutations represent the most frequent oncogenic driver lesion found across all human cancers. Given that single PIK3CA mutations are a predictive biomarker for response to PI3K inhibition, and that these clinical benefits are small,… read more here.

Keywords: response; compound; pik3ca; cancer ... See more keywords
Photo from wikipedia

PIK3CA Mutations Induce Neuronal Hyperactivity during Glioma Formation.

Sign Up to like & get
recommendations!
Published in 2020 at "Cancer discovery"

DOI: 10.1158/2159-8290.cd-rw2020-019

Abstract: Two glioma driver mutations in PIK3CA promote neuronal hyperactivity via distinct mechanisms. read more here.

Keywords: glioma; induce neuronal; mutations induce; neuronal hyperactivity ... See more keywords
Photo by sangharsh_l from unsplash

Molecular, Histological, and Clinical Characteristics of Oligodendrogliomas: A Multi-Institutional Retrospective Study

Sign Up to like & get
recommendations!
Published in 2022 at "Neurosurgery"

DOI: 10.1227/neu.0000000000001875

Abstract: BACKGROUND: Reports suggest that phosphatidylinositol 3-kinase pathway alterations confer increased risk of progression and poor prognosis in oligodendroglioma, IDH-mutant, and 1p/19q-codeleted molecular oligodendrogliomas (mODG). However, factors that affect prognosis in mODG have not been thoroughly… read more here.

Keywords: modgs; pfs; pik3ca mutations; radiation ... See more keywords